
Israeli researchers developing radioactive marker to detect small, aggressive cancerous tumors
Marker will determine type of tumor in a single image, eliminating the need for a biopsy Today, more than 200,000 cancer patients and persons in
Home page » Career
Marker will determine type of tumor in a single image, eliminating the need for a biopsy Today, more than 200,000 cancer patients and persons in
Jubilant Radiopharma and Isotopia Molecular Imaging Enter into a Strategic Partnership to Further Advance the Field of Radiotherapeutics Our latest news Our latest news Yardley,
Isotopia and M.T.T.I signed for the supply of Lu-177 n.c.a Isotopia Molecular Imaging and Molecular Targeting Technologies (M.T.T.I) havesigned a clinical supply agreement for Lu177
18-2-2021 Lu177 is better than cabazitaxel in patients with metastatic castration-resistant prostate cancer. An unblinded, randomized phase 2 trial at 11 centers in Australia. the
Residence- ISRAEL, Petah-Tikva Responsibility: Responsible for the company’s global sales. Develop new markets, maintain and maximize the sales potential of existing customers. Description & Key
Isotopia Molecular Imaging הינה חברה ישראלית גלובלית העוסקת בתחום הרפואה הגרעינית. החברה נושאת על דגלה את סמל החדשנות ומביאה ללקוחותיה בארץ ובעולם מוצרי אבחון וטיפול
Get in touch…